Trial intelligence / Profile preview

Follicular steroid synthesis with recombinant FSH vs HMG in GnRH antagonist cycles

2015-005762-28Phase 4Completed

Sponsor
International Vaccine Institute
Start
Feb 2016
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of follitropin alfa and human menopausal gonadotrophin (2 arms), sponsored by International Vaccine Institute. Primary endpoint: Area under the curve of follicular steroids and gonadotropins during ovarian stimulation. Started Feb 2016; status: completed.

02

Drugs

follitropin alfahuman menopausal gonadotrophin

Beyond the preview

Go deeper on 2015-005762-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-005762-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call